RT Journal
A1 Voelker R
T1 CHildren’s exposure to testosterone gel spurs fda to order boxed label warning
JF JAMA
JO JAMA
YR 2009
FD June 17
VO 301
IS 23
SP 2428
OP 2428
DO 10.1001/jama.2009.810
UL http://dx.doi.org/10.1001/jama.2009.810
AB 
The gels are approved for use in men who produce little or no testosterone. They are applied topically to the shoulders or upper arms; AndroGel 1% is approved for application to the abdomen. Current label instructions advise patients to wash their hands and cover the treated area with clothing after using the product. The FDA noted that most cases of adverse events in children occurred because patients failed to follow the label instructions, resulting in skin-to-skin contact with a child.